Oragenics (OGEN) Competitors $1.35 -0.08 (-5.59%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.38 +0.02 (+1.85%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OGEN vs. THAR, RDHL, SNGX, TTNP, SPRB, CMND, ADIL, SPRC, VRAX, and NBYShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Tharimmune (THAR), Redhill Biopharma (RDHL), Soligenix (SNGX), Titan Pharmaceuticals (TTNP), Spruce Biosciences (SPRB), Clearmind Medicine (CMND), Adial Pharmaceuticals (ADIL), SciSparc (SPRC), Virax Biolabs Group (VRAX), and NovaBay Pharmaceuticals (NBY). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Its Competitors Tharimmune Redhill Biopharma Soligenix Titan Pharmaceuticals Spruce Biosciences Clearmind Medicine Adial Pharmaceuticals SciSparc Virax Biolabs Group NovaBay Pharmaceuticals Oragenics (NYSE:OGEN) and Tharimmune (NASDAQ:THAR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Does the media prefer OGEN or THAR? In the previous week, Oragenics had 1 more articles in the media than Tharimmune. MarketBeat recorded 1 mentions for Oragenics and 0 mentions for Tharimmune. Oragenics' average media sentiment score of 0.00 equaled Tharimmune'saverage media sentiment score. Company Overall Sentiment Oragenics Neutral Tharimmune Neutral Do analysts prefer OGEN or THAR? Tharimmune has a consensus target price of $17.00, indicating a potential upside of 905.92%. Given Tharimmune's stronger consensus rating and higher probable upside, analysts plainly believe Tharimmune is more favorable than Oragenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oragenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tharimmune 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is OGEN or THAR more profitable? Tharimmune's return on equity of -489.33% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% Tharimmune N/A -489.33%-264.34% Which has more volatility and risk, OGEN or THAR? Oragenics has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Tharimmune has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Do institutionals & insiders have more ownership in OGEN or THAR? 18.7% of Oragenics shares are held by institutional investors. Comparatively, 1.2% of Tharimmune shares are held by institutional investors. 4.9% of Oragenics shares are held by company insiders. Comparatively, 10.0% of Tharimmune shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, OGEN or THAR? Tharimmune is trading at a lower price-to-earnings ratio than Oragenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenicsN/AN/A-$20.66M-$33.63-0.04TharimmuneN/AN/A-$12.20M-$7.88-0.21 SummaryTharimmune beats Oragenics on 10 of the 13 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.11M$817.60M$5.55B$20.85BDividend YieldN/A4.84%3.75%3.65%P/E Ratio-0.191.4128.0127.56Price / SalesN/A27.13432.8159.11Price / CashN/A19.5636.1622.29Price / Book2.216.878.124.66Net Income-$20.66M-$4.17M$3.25B$994.58M7 Day Performance-4.93%-0.12%1.68%-0.29%1 Month Performance-63.61%1.85%7.30%4.90%1 Year Performance-95.59%4.45%32.89%11.14% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenics0.0606 of 5 stars$1.35-5.6%N/A-95.6%$1.11MN/A-0.195THARTharimmune3.1996 of 5 stars$1.68flat$17.00+911.9%-55.5%$4.47MN/A-0.212Positive NewsRDHLRedhill BiopharmaN/A$1.92+0.5%N/A-99.2%$4.42M$8.04M0.00210News CoveragePositive NewsSNGXSoligenix2.4547 of 5 stars$1.32+5.5%$6.00+354.9%-78.7%$4.30M$120K-0.3120Analyst ForecastTTNPTitan Pharmaceuticals0.0382 of 5 stars$4.70+2.4%N/A-28.0%$4.28M$180K-1.0210Positive NewsSPRBSpruce Biosciences2.4697 of 5 stars$0.10+3.5%$1.75+1,650.0%-79.9%$4.22M$4.91M-0.1120Gap UpCMNDClearmind Medicine0.9021 of 5 stars$0.98+0.8%N/A-41.5%$4.19MN/A-0.89N/AADILAdial Pharmaceuticals2.7324 of 5 stars$0.39+4.6%$8.00+1,977.9%-57.4%$4.02MN/A-0.2620SPRCSciSparc0.4564 of 5 stars$7.35+2.2%N/A-50.8%$3.89M$1.31M0.004VRAXVirax Biolabs Group2.165 of 5 stars$0.90+2.9%$3.00+235.2%-16.5%$3.79M$10K0.005News CoveragePositive NewsNBYNovaBay Pharmaceuticals1.6038 of 5 stars$0.65-3.0%$0.85+30.8%-67.2%$3.78M$9.78M-0.0130 Related Companies and Tools Related Companies Tharimmune Competitors Redhill Biopharma Competitors Soligenix Competitors Titan Pharmaceuticals Competitors Spruce Biosciences Competitors Clearmind Medicine Competitors Adial Pharmaceuticals Competitors SciSparc Competitors Virax Biolabs Group Competitors NovaBay Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGEN Stock Alerts